Ji Youn Kim1, Sung Hun Kim2, Yun Ju Kim3, Bong Joo Kang3, Yeong Yi An4, A Won Lee5, Byung Joo Song6, Yong Soo Park7, Han Bi Lee7. 1. Department of Radiology, St. Mary's Hospital, The College of Medicine, The Catholic University of Korea. 2. Department of Radiology, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea. Electronic address: rad-ksh@catholic.ac.kr. 3. Department of Radiology, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea. 4. Department of Radiology, St. Vincent's Hospital, The College of Medicine, The Catholic University of Korea. 5. Department of Hospital Pathology, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea. 6. Department of General Surgery, Seoul St. Mary's Hospital, The College of Medicine, The Catholic University of Korea. 7. The College of Medicine, The Catholic University of Korea.
Abstract
OBJECTIVE: To correlate the enhancement parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with prognostic factors and immunohistochemical subtypes of breast cancer. MATERIAL AND METHODS: A total of 81 breast carcinomas were included in our study. We obtained the following enhancement parameters: 1) analysis of background parenchymal enhancement (BPE) and BPE coefficients (BEC) from bilateral breasts, 2) the number of vessels per breast as a representation of ipsilateral whole-breast vascularity. Additionally, in 50 patients, 3) semiquantitative parameters of tumors (the initial enhancement percentage (E1), the peak enhancement percentage (Epeak), the time to peak enhancement (TTP), the signal enhancement ratio (SER)) and 4) perfusion parameters (K(trans), kep, ve and iAUC) from tumors and ipsilateral breasts were also obtained. Correlations among parameters and prognostic factors, including tumor size, axillary node status, nuclear grade, histologic grade, estrogen receptor (ER) expression, progesterone receptor (PR) expression, Ki-67, human epidermal growth factor receptor 2 (HER-2) expression, epidermal growth factor receptor (EGFR) expression, bcl-2, CK5/6 and subtypes categorized as luminal (ER or PR positive), triple negative (ER or PR negative, HER-2 negative) and HER2 (ER and PR negative with HER-2 overexpression) were analyzed. RESULTS: BPE was significantly correlated with EGFR expression (p=0.040). BEC was significantly higher in tumors larger than 2cm than in tumors smaller than 2cm (p=0.001). The vessel numbers in ipsilateral breasts were higher in tumors larger than 2cm than in tumors smaller than 2cm (p=0.034), with higher nuclear grades (grade 3) than with lower nuclear grades (grade 1,2) (p=0.001) and with PR-negative rather than with PR-positive (p=0.010) results. The mean K(trans) was higher in Ki-67-positive tumors than Ki-67 negative tumors (p=0.002). The mean kep was higher in Ki-67-positive tumors than in Ki-67-negative tumors (p=0.005) and in CK5/6-positive tumors than in CK5/6-negative tumors (p=0.015). The mean K(trans) was lower in the ipsilateral breast parenchyma with HER-2-positive tumors compared to HER-2-negative tumors (p=0.012). CONCLUSION: BPE, BEC and ipsilateral whole-breast vascularity, higher K(trans) and kep of the cancer and lower K(trans) and iAUC of ipsilateral breast parenchyma may serve as additional predictors of a poor breast cancer prognosis.
OBJECTIVE: To correlate the enhancement parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) with prognostic factors and immunohistochemical subtypes of breast cancer. MATERIAL AND METHODS: A total of 81 breast carcinomas were included in our study. We obtained the following enhancement parameters: 1) analysis of background parenchymal enhancement (BPE) and BPE coefficients (BEC) from bilateral breasts, 2) the number of vessels per breast as a representation of ipsilateral whole-breast vascularity. Additionally, in 50 patients, 3) semiquantitative parameters of tumors (the initial enhancement percentage (E1), the peak enhancement percentage (Epeak), the time to peak enhancement (TTP), the signal enhancement ratio (SER)) and 4) perfusion parameters (K(trans), kep, ve and iAUC) from tumors and ipsilateral breasts were also obtained. Correlations among parameters and prognostic factors, including tumor size, axillary node status, nuclear grade, histologic grade, estrogen receptor (ER) expression, progesterone receptor (PR) expression, Ki-67, humanepidermal growth factor receptor 2 (HER-2) expression, epidermal growth factor receptor (EGFR) expression, bcl-2, CK5/6 and subtypes categorized as luminal (ER or PR positive), triple negative (ER or PR negative, HER-2 negative) and HER2 (ER and PR negative with HER-2 overexpression) were analyzed. RESULTS: BPE was significantly correlated with EGFR expression (p=0.040). BEC was significantly higher in tumors larger than 2cm than in tumors smaller than 2cm (p=0.001). The vessel numbers in ipsilateral breasts were higher in tumors larger than 2cm than in tumors smaller than 2cm (p=0.034), with higher nuclear grades (grade 3) than with lower nuclear grades (grade 1,2) (p=0.001) and with PR-negative rather than with PR-positive (p=0.010) results. The mean K(trans) was higher in Ki-67-positive tumors than Ki-67 negative tumors (p=0.002). The mean kep was higher in Ki-67-positive tumors than in Ki-67-negative tumors (p=0.005) and in CK5/6-positive tumors than in CK5/6-negative tumors (p=0.015). The mean K(trans) was lower in the ipsilateral breast parenchyma with HER-2-positive tumors compared to HER-2-negative tumors (p=0.012). CONCLUSION: BPE, BEC and ipsilateral whole-breast vascularity, higher K(trans) and kep of the cancer and lower K(trans) and iAUC of ipsilateral breast parenchyma may serve as additional predictors of a poor breast cancer prognosis.
Authors: Marco Macchini; Martina Ponziani; Andrea Prochowski Iamurri; Mirco Pistelli; Mariagrazia De Lisa; Rossana Berardi; Gian Marco Giuseppetti Journal: Radiol Med Date: 2018-06-05 Impact factor: 3.469
Authors: Jamal J Derakhshan; Elizabeth S McDonald; Evan S Siegelman; Mitchell D Schnall; Felix W Wehrli Journal: Magn Reson Med Date: 2017-08-24 Impact factor: 4.668
Authors: H Preibsch; L Wanner; S D Bahrs; B M Wietek; K C Siegmann-Luz; E Oberlecher; M Hahn; A Staebler; K Nikolaou; B Wiesinger Journal: Eur Radiol Date: 2015-09-17 Impact factor: 5.315
Authors: Nathaniel E Margolis; Linda Moy; Eric E Sigmund; Melanie Freed; Jason McKellop; Amy N Melsaether; Sungheon Gene Kim Journal: Clin Nucl Med Date: 2016-08 Impact factor: 7.794